Menu
Back to Journals » Clinical, Cosmetic and Investigational Dermatology » Volume 17
A Case of Erythrodermic Psoriasis Successfully Treated with Risankizumab [Corrigendum]
Authors Megna M, Ruggiero A , Salsano A, Lauletta G , Portarapillo A , Torta G, Martora F , Potestio L
Received 14 June 2024
Accepted for publication 14 June 2024
Published 18 June 2024 Volume 2024:17 Pages 1447—1448
Megna M, Ruggiero A, Salsano A, et al. Clin Cosmet Investig Dermatol. 2023;16:3503–3507.
The authors have advised that the study did not receive any funding. The funding statement “Medical writing was funded through a donation by Abbvie Srl” on page 3506 should be removed.
The authors apologize for this error.
© 2024 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.